717 related articles for article (PubMed ID: 18991870)
1. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury.
Sharma HS; Ali SF
Ann N Y Acad Sci; 2008 Oct; 1139():242-58. PubMed ID: 18991870
[TBL] [Abstract][Full Text] [Related]
2. Cocaine-induced breakdown of the blood-brain barrier and neurotoxicity.
Sharma HS; Muresanu D; Sharma A; Patnaik R
Int Rev Neurobiol; 2009; 88():297-334. PubMed ID: 19897082
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches.
Sharma HS; Johanson CE
Ann N Y Acad Sci; 2007 Dec; 1122():112-29. PubMed ID: 18077568
[TBL] [Abstract][Full Text] [Related]
4. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
Adori C; Andó RD; Kovács GG; Bagdy G
J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors influence dynorphin A (1-17) immunoreactivity in the rat brain following hyperthermia.
Sharma HS; Alm P
Amino Acids; 2002; 23(1-3):247-59. PubMed ID: 12373545
[TBL] [Abstract][Full Text] [Related]
6. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
7. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus.
Bowyer JF; Ali S
Synapse; 2006 Dec; 60(7):521-32. PubMed ID: 16952162
[TBL] [Abstract][Full Text] [Related]
8. Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.
Brown PL; Kiyatkin EA
Eur J Neurosci; 2004 Jul; 20(1):51-8. PubMed ID: 15245478
[TBL] [Abstract][Full Text] [Related]
9. Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats.
Sharma HS; Hussain S; Schlager J; Ali SF; Sharma A
Acta Neurochir Suppl; 2010; 106():359-64. PubMed ID: 19812977
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.
Pérez-Hernández M; Fernández-Valle ME; Rubio-Araiz A; Vidal R; Gutiérrez-López MD; O'Shea E; Colado MI
Neuropharmacology; 2017 May; 118():157-166. PubMed ID: 28322979
[TBL] [Abstract][Full Text] [Related]
11. Chronic hypertension aggravates heat stress induced cognitive dysfunction and brain pathology: an experimental study in the rat, using growth hormone therapy for possible neuroprotection.
Muresanu DF; Sharma HS
Ann N Y Acad Sci; 2007 Dec; 1122():1-22. PubMed ID: 18077561
[TBL] [Abstract][Full Text] [Related]
12. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia.
Kiyatkin EA; Brown PL; Sharma HS
Eur J Neurosci; 2007 Sep; 26(5):1242-53. PubMed ID: 17767502
[TBL] [Abstract][Full Text] [Related]
13. Alterations in blood-brain barrier function by morphine and methamphetamine.
Sharma HS; Ali SF
Ann N Y Acad Sci; 2006 Aug; 1074():198-224. PubMed ID: 17105918
[TBL] [Abstract][Full Text] [Related]
14. Alterations in blood-brain barrier function and brain pathology by morphine in the rat. Neuroprotective effects of antioxidant H-290/51.
Sharma HS; Sjöquist PO; Ali SF
Acta Neurochir Suppl; 2010; 106():61-6. PubMed ID: 19812922
[TBL] [Abstract][Full Text] [Related]
15. A new antioxidant compound H-290/51 attenuates nanoparticle induced neurotoxicity and enhances neurorepair in hyperthermia.
Sharma HS; Sharma A; Hussain S; Schlager J; Sjöquist PO; Muresanu D
Acta Neurochir Suppl; 2010; 106():351-7. PubMed ID: 19812976
[TBL] [Abstract][Full Text] [Related]
16. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Darvesh AS; Gudelsky GA
Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
[TBL] [Abstract][Full Text] [Related]
17. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
[TBL] [Abstract][Full Text] [Related]
18. Heat-shock protein and C-fos expression in focal microvascular brain damage.
Lindsberg PJ; Frerichs KU; Sirén AL; Hallenbeck JM; Nowak TS
J Cereb Blood Flow Metab; 1996 Jan; 16(1):82-91. PubMed ID: 8530560
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation and astrocytic reaction in the course of Phoneutria nigriventer (armed-spider) blood-brain barrier (BBB) opening.
da Cruz-Höfling MA; Rapôso C; Verinaud L; Zago GM
Neurotoxicology; 2009 Jul; 30(4):636-46. PubMed ID: 19393263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
